plants


Supreme Cannabis Strengthens Sales Strategy with New Senior Vice President of Commercial

November 4th, 2019 - Ash Stringer

Joel Toguri joins as Senior Vice President of Commercial Supreme Cannabis strengthens senior team with the addition of experienced sales executive Toguri brings over 20 years of regulated industry expertise to Supreme Cannabis TORONTO, November 4, 2019 – The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) announced today […]

Snoop Dogg “Down With” Israeli Cannabis Company, Highlights Investment in the Country

October 30th, 2019 - Ash Stringer

Vocal cannabis activist Snoop Dogg has signed on as a brand ambassador for Israeli start-up Seedo (OTC: SEDO), the maker of a refrigerator-type of a machine for auto-growing plants, including cannabis. The indelible award-winning rapper says he’s “all the way down with” the Seedo Homelab and the utility it brings to allow people to grow […]

New Report: Women Prefer Cannabis Strains High in CBD

October 30th, 2019 - Ryan Allway

RYAH Finds Top Priority is Treating Mental Health, Over 28,000 Women Surveyed New York, NY, October 30, 2019 – RYAH Medtech, Inc. (“RYAH” or the “Company”), a big data and technology company focused on valuable predictive analysis in the global medical plant intake industry, has released a data analytics report on women and their medical […]

RYAH Medtech, Inc. Signs Major Purchase Order with International Pharmaceutical Company

October 29th, 2019 - Ryan Allway

New York, NY, October 29, 2019 – RYAH Medtech, Inc. (“RYAH” or the “Company”), a big data and technology company focused on valuable predictive analysis in the global medical plant intake industry, announced today that it has signed an agreement with an international clinic (the “Clinic”) for one of the world’s largest and most comprehensive […]

Isracann Biosciences Launches Phase One Facility Development Program in Israel

October 28th, 2019 - Ryan Allway

Company aims to develop top regional cannabis brands for entry into EU marketplace VANCOUVER, British Columbia, Oct. 28, 2019 (GLOBE NEWSWIRE) — Isracann Biosciences Inc.  (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) is pleased to provide an operative overview and update regarding facility development activities in Israel. Concurrent to […]

Leading Israeli Cannabis Company Goes Public

October 24th, 2019 - Ryan Allway

Rolling Stone magazine has called Israel a “medical weed wonderland.” Former Israeli Prime Minister Ehud Barack said earlier this year that the “Land of Milk and Honey” is now the “Land of Milk, Honey and Cannabis.” The man that discovered cannabinoids, Dr. Raphael Mechoulam, did so there and continues to conduct his research there to […]

Benzinga Cannabis Capital Conference Connecting Cannabis Investors & Executives in Chicago

October 21st, 2019 - Ryan Allway

The Benzinga Cannabis Capital Conference will take place at Chicago’s Palmer House on October 22 and 23, 2019. Cannabis investors will have a chance to come face-to-face with cannabis companies to hear about their advancements in the rapidly growing industry, while cannabis executives will have an opportunity to grow their business and attract investors with […]

Isracann Biosciences Announces Listing on the CSE and Investor Relations Agreements

October 17th, 2019 - Ryan Allway

VANCOUVER, British Columbia, Oct. 16, 2019 (GLOBE NEWSWIRE) — Isracann Biosciences Inc.  (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company”) is pleased to announce the fulfillment of all conditions of its reverse takeover transaction and that the Company has met all conditions to list on the Canadian Securities […]

DNA Genetics Names Rakaa Taylor as Director of Marketing

October 15th, 2019 - Ryan Allway

Leading Global Cannabis Brand Selects Seasoned Marketing Manager, Brand Specialist, Creative Director and Hip Hop Veteran to Head Marketing Operations LOS ANGELES, Oct. 01, 2019 (GLOBE NEWSWIRE) — OG DNA Genetics (“DNA”, “DNA Genetics”, or the “Company”), a globally recognized leading cannabis brand, announced today that Rakaa Taylor will be joining the executive team as […]

Priming for Expansion, GreenStar Strikes a Deal with Progressive Herbs

October 10th, 2019 - Ryan Allway

GreenStar Biosciences Corp. (CSE: GSTR) already had a strong cannabis market presence through its stake in Cowlitz County Cannabis Cultivation, a leading player in Washington State. Primed for expansion, GreenStar has struck a deal with Progressive Herbs Inc., forging a new joint venture that should make all involved even stronger. Cowlitz County Cannabis is a […]

THC BioMed Planning for New Product Launches

October 9th, 2019 - Ash Stringer

THC BioMed Intl Ltd. (“THC BioMed”) has submitted a new product application for its Pure Cannabis Sticks and is developing a cannabis beverage called “THC Kiss.” Both products are subject to Health Canada approval. The Government of Canada has announced that the production and sale of cannabis edibles, extracts and topicals will be legalized on […]

CWCB Expo Los Angeles Connecting Cannabis Leaders & Investors

September 19th, 2019 - Ryan Allway

There are many difference cannabis industry conferences occurring every week in North America and around the world, but few are as iconic as the Cannabis World Congress & Business Exposition, which holds three events per year in New York, Los Angeles, and Boston. The upcoming Cannabis World Congress & Business Exposition (CWCB Expo) in Los […]

Europe: The Cannabis Industry’s Next Emerging Market

September 19th, 2019 - Ryan Allway

The global cannabis industry is projected to reach $66.3 billion by 2025, according to Grand View Research, representing a 23.9 percent compound annual growth rate. While North America has become a market leader, European markets are quickly catching up with their own liberalized laws. The market for health and wellness products, such as cannabidiol (CBD) […]

CBD Playing an Increasing Role in Health & Wellness

September 17th, 2019 - Tony Deyes

The legalization of cannabis has enabled far greater research into the potential medicinal benefits offered by the plant – especially cannabidiol (CBD), the most abundant non-psychoactive cannabinoid found in both cannabis and hemp. This increased research has led to the creation of hundreds of new and innovative alternatives to health and wellness products.  Rapidly Changing […]

A Leader In Washington, GreenStar Eyes Expansion

September 10th, 2019 - Ash Stringer

Washington State has long been a pioneer in the cannabis industry. Medical marijuana has been legal since 1998 and the state was the first in the U.S. to approve recreational marijuana, doing so on December 6, 2012. The market continues to grow, including retail sales reaching $972 million in 2018 from $851 million in 2017. […]

Sweet Citrus Spice! Supreme Cannabis’ 7ACRES Launches New Sativa Cultivar

September 10th, 2019 - Ash Stringer

In recent years, consumers growing tired of bland beer with low-quality ingredients undergirded a craft beer movement that is still gaining steam. In fact, while overall beer volume sales dipped in 2018, craft beer sales increased 4% by volume and 7% by dollar sales, climbing to 24% of the $114.2 billion U.S. beer market. The point […]

A Look Under the Rug at the Savvy Penetration of Europe’s Cannabis Market by Supreme Heights

September 6th, 2019 - Ryan Allway

As the nascent European legal cannabis market emerges, Canadian companies that have cut their teeth in their home markets are taking that experience overseas to capitalize on a much larger market opportunity. The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) is a model of how to build a successful cannabis portfolio at a blistering […]

Want a Powerplay Cannabis Brand? Know Your Consumer

September 6th, 2019 - Ash Stringer

With recreational or medical marijuana allowed in 33 U.S. states, about 224 million people now have legal access to cannabis. An April Hill-HarrisX poll showed that 84% of Americans now support legalizing marijuana, including 42% of respondents expressing their belief it should be legal for any use. The growing approval rates for cannabis signal a […]

Four Things to Look Forward to at Cannabis Science Conference West

September 4th, 2019 - Rachelle Gordon

The Cannabis Science Conference West officially begins tomorrow with a schedule jam-packed with inspiring and innovative speakers, dynamic presentations, a bustling expo floor – and of course, the parties. Thousands of industry entrepreneurs, experts, and enthusiasts are expected to turn out to the Portland Convention Center for two days of education, networking, and fellowship.  “We’re […]

Supreme Cannabis Pulling Away From Peers, Guides Up to $180 Million in 2020 Revenue

August 15th, 2019 - Ash Stringer

While still in its infancy, the cannabis industry has reached an inflection point where some clear separation is happening between companies. To use some old axioms, “The cream is rising to the top” and “The wheat is being separated from the chaff,” if you will.   Companies with strong operations and core businesses are being positioned […]

More Companies Lining Up to Get Their Hands on Lexaria’s DehydraTECH™ Platform

August 15th, 2019 - Ash Stringer

When you’ve got something great, it may take a little bit of time for people to learn about it, but once word starts getting around, it can yield a windfall of interest. That’s the case with Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and its DehydraTECH™ technology that enhances qualities and uptake of all sorts […]

XPhyto Therapeutics Debuts on CSE Under Ticker XPHY

August 6th, 2019 - Ryan Allway

  After about two years of building relationships with exceptional partners and positioning itself in Canada and Europe, XPhyto Therapeutics (CSE: XPHY) was ready to become a public company. That happened Tuesday morning, with trading beginning on the Canadian Securities Exchange, checking off one more box on management’s list of accomplishments. Click here to receive […]

DNA Genetics’ Charles Phillips Talks Cannabis Branding with CFN Media

August 5th, 2019 - Ash Stringer

As the cannabis market moves from the back alley to the boardroom, we are gaining an increasing appreciation for the role genetics play in developing distinct varieties with unique medical and commercial application. As the cannabis market matures, the significance of genetic selection is quickly becoming a focus of the discussion. Cannabis has been loosely […]

Cannabis M&A Spree Continues with Supreme’s Merger with Blissco

August 2nd, 2019 - Ash Stringer

The cannabis industry is quickly moving through a well-known cycle for emerging markets. Like Google in the tech industry, early market entrants that have become successful in a given subset of the fragmented market are starting to look to mergers and acquisitions to expand their geographic and product footprint. The result is often a mature […]

XPhyto Therapeutics Ready to Be Cannabis’ Newest Public Entity

August 2nd, 2019 - Ryan Allway

Only days after announcing that its wholly owned subsidiary was awarded a German cannabis and cultivation and extraction licence, XPhyto Therapeutics is ready to enter the public domain. With a final prospectus filed with the British Columbia Securities Commission, XPhyto is ready to go public on the CSE under the ticker “XPHY”. The company will […]

CannabisFN Profile: Recognizable Cannabis Advocate, Steve DeAngelo & Harborside Inc.

July 30th, 2019 - Ryan Allway

There are many celebrities that have been involved in the cannabis industry, but few have been as actively involved in the community as Steve DeAngelo. As a pioneering cannabis entrepreneur, activist, author and on-screen personality, DeAngelo co-founded several iconic cannabis businesses and organizations and continues to play an instrumental role in reforming cannabis laws through […]

RYAH Signs Partnership Agreement With SOS Cannabis for Reimbursement for Canadian Patients

July 29th, 2019 - Ryan Allway

NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) — RYAH Medtech Inc. (“RYAH” or the “Company”), announced today it has executed a partnership agreement with SOS cannabis (“SOS Cannabis”). The agreement will provide Canadian patients with the ability to obtain free legal representation to seek reimbursement from different government agencies for the medical costs associated with […]

XPhyto Therapeutics: Where Medical Cannabis Meets Modern Science

July 25th, 2019 - Ryan Allway

  It wasn’t long ago that recreational marijuana was legalized in Washington State and Colorado, while speculation about widespread medical marijuana was running rampant across America and then-Canadian Prime Minister candidate Justin Trudeau was making campaign promises for his country to become the second in the world with adult-use marijuana. At that time, so-called “pot […]

First, Last and Always: Cannabis Innovation Never Ends in Israel

July 25th, 2019 - Ash Stringer

When the word “cannabis” is heard, “Israel” probably isn’t one of the first things that jumps to mind. But, for investors it should be. For that matter, so should EuroMed Therapeutics, an upstart heading toward the public domain. Here’s why. Top Notch R&D, Perfect Weather and Locale  First, simply consider the overall startup picture and […]

Strainwise Looks to Build a Cannabis Services Ecosystem

July 22nd, 2019 - Ryan Allway

The global cannabis industry is projected to reach more than $66.3 billion by 2025, according to Grand View Research, which represents a blistering 23.9% compound annual growth rate. There are many different opportunities for investors interested in the space, ranging from cultivators to REITs, but consulting businesses have some unique advantages. For example, they often […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading